RTM
LIVE

Serial Number

79179512

Owner

Neurimmune Holding AG

Attorney

Janice Housey

Filing Date

Aug 14, 2015

Add to watchlist:

No watchlists yet
View on USPTO

RTM Trademark

Serial Number: 79179512 • Registration: 5238541

RTM is a trademark filed by Neurimmune Holding AG on August 14, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Neurimmune Holding AG (16 trademarks)

Wagistrasse 18

Entity Type: 25

Trademark Details

Filing Date

August 14, 2015

Registration Date

July 11, 2017

Published for Opposition

April 25, 2017

Goods & Services

[ Pharmaceutical preparations for use in the treatment of diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations for use in the treatment of diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the removal of tumors; pharmaceutical preparations for neurodegenerative diseases; pharmaceutical preparations, namely, immunogens for medical use; vaccines, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological disease; epitopes for pharmaceutical use for use in attaching to antibodies for in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological disease; peptides for pharmaceutical purposes for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biological preparations for medical use, namely, pharmaceutical preparations for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biocides; diagnostic products, namely, diagnostic preparations for medical and veterinary use; pre-moistened medicated towels for hygiene purposes; dietetic foods, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea adapted for medical use; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; protein antibodies for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing ]

[ Chemicals used in industry; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes, namely, cell cultures, tissue cultures, chemical and biological assays; biological preparations for use in cell cultures other than for medical or veterinary use; peptides for chemical products and foodstuffs, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; polypeptides for use in diagnostic and therapeutic agents except for medical or veterinary use; antibodies and proteins for scientific use ]

[ Medical services; medical services in the field of immunity; provision of medical information; medical examinations; preparation and dispensing of medicines; nutritional consultancy and dietary consultancy relating to nutrition; medical consultancy and provision of medical information in the field of sanitary care; veterinary services, namely, veterinary assistance; beauty salon services; veterinary care services for animals; hygienic care; consultancy and provision of information relating to the dispensing and preparation of pharmaceutical preparations ]

[ Monitoring and inspection for the quality control and scientific analysis of active substances; ] pharmaceutical research; [ scientific research in the field of cosmetics and foodstuffs; consultancy and information on monitoring and inspection for the quality control and scientific analysis of active substances; ] scientific consultation relating to research involving pharmaceutical products; [ scientific consultation relating to research in the field of cosmetics and foodstuffs; monitoring and inspection for the quality control and scientific analysis of active substances; ] scientific research involving medical treatment and methods; scientific research in the fields of biotechnology and antibodies; [ information on monitoring and inspection for the quality control and scientific analysis of active substance; ] scientific testing and research in technical and medical treatment relating to active substances; [ scientific research in the field of sanitary care; ] scientific monitoring, inspection and research in the field of biology; consultancy and provision of information relating to quality control of pharmaceutical preparations; [ software maintenance, computer software design, computer programming; design and development of computer hardware; software development; software maintenance; ] all of the foregoing related to pharmaceutical preparations, medical and veterinary purposes and related to the treatment, diagnosis and prevention of human diseases

Filing History

INTERNATIONAL REGISTRATION RENEWED
Jul 10, 2025 RNWL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 12, 2025 COAR
PARTIAL INVALIDATION PROCESSED BY THE IB
May 6, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 20, 2024 INPS
INVALIDATION PROCESSED
Mar 20, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 12, 2024 INPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 10, 2023 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 12, 2023 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 12, 2023 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 4, 2023 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 15, 2022 ES75
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 4, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jan 31, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 3, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 16, 2017 FICS
FINAL DISPOSITION PROCESSED
Oct 16, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 11, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2017 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 16, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 31, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 31, 2017 OPNR
PUBLISHED FOR OPPOSITION
Apr 25, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Apr 22, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 5, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 5, 2017 OP2R
NOTICE OF PUBLICATION
Apr 5, 2017 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 20, 2017 PREV
EXPARTE APPEAL TERMINATED
Mar 15, 2017 EXPT
EXAMINERS AMENDMENT MAILED
Mar 15, 2017 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 15, 2017 XAEC
EXAMINERS AMENDMENT -WRITTEN
Mar 15, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2017 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 9, 2017 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2017 CRFA
ASSIGNED TO LIE
Feb 6, 2017 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 19, 2017 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 19, 2017 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 19, 2017 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 19, 2017 EXAF
FINAL REFUSAL MAILED
Jul 19, 2016 CNFR
FINAL REFUSAL WRITTEN
Jul 19, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2016 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Mar 18, 2016 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 4, 2016 NREP
REFUSAL PROCESSED BY IB
Feb 1, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 11, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jan 11, 2016 RFRR
APPLICATION FILING RECEIPT MAILED
Jan 8, 2016 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 6, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jan 5, 2016 CNRT
ASSIGNED TO EXAMINER
Jan 4, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2016 REPR